HAPLN4 and neuroblastoma: The upregulation of genes BSG/CD147, CCDC125, GABRB3, GNB2L1/RACK1, HAPLN4, HEBP2, and HSD17B12 is associated with poor neuroblastoma prognosis and low EFS.